Anil Kukreja

Feasibility of molecular testing in a multicenter study with geographical variation in India: Epidermal growth factor receptor mutation as a model molecular test

A. Dutt, Rajiv Kumar, K. Prabhash, 2017, Asian Journal of Oncology.

Pertuzumab: Unprecedented benefit in human epidermal growth factor receptor 2-positive breast cancer

P. Dattatreya, M. Singhal, A. Rauthan, 2015, Asian Journal of Oncology.

Meeting report, “First Indian national conference on cervical cancer management - expert recommendations and identification of barriers to implementation”

S. Rawat, K. Tewari, N. Huilgol, 2018, Gynecologic Oncology Research and Practice.